
Manulife Financial Corporation reported strong Q2 2026 results, with a 21% year-over-year increase in Annual Premium Equivalent (APE) sales reaching CAD 2.7 billion, driven mainly by growth in Asia and new product launches. Core earnings also rose 12% to over CAD 1.9 billion, supported by robust credit quality and minimal expected credit loss provisions. The company maintains a solid capital position, enabling sustainable dividends and shareholder returns. Despite these positive fundamentals, the current valuation at 2.13 times price-to-book value appears high, suggesting investors might consider taking profits or waiting for a better entry point.